Target intelligence / Profile preview

Blue light (High-energy visible light) (HEV)

Target
HEV
Molecular classification
Other
01

Overview

Blue light, or high-energy visible (HEV) light, refers to the 400-500 nm wavelength range of the visible spectrum that reaches the macular and retinal tissues [1]. It is not a biological molecule or receptor but a physical stimulus that interacts with various retinal chromophores, most notably melanopsin (OPN4) for circadian regulation and A2E (a component of lipofuscin) for photochemical reactions [2, 3]. While blue light is essential for non-image-forming visual functions and color vision, chronic or intense exposure is associated with the generation of reactive oxygen species (ROS) and oxidative stress in the retinal pigment epithelium (RPE) and photoreceptors [1, 4]. This phototoxicity is a significant contributing factor to the pathogenesis and progression of age-related macular degeneration (AMD) [4]. Therapeutic strategies do not target blue light in the traditional pharmacological sense; instead, they involve the use of macular pigments such as lutein and zeaxanthin, which act as internal filters to absorb blue light and as antioxidants to mitigate oxidative damage [5]. Additionally, visual cycle modulators like emixustat are being investigated to reduce the accumulation of blue light-sensitive chromophores like A2E to prevent retinal phototoxicity [6]. References: [1] Hunter et al., Prog Retin Eye Res, 2012; [2] UniProt, Q9UHM6; [3] Sparrow et al., J Biol Chem, 2000; [4] Ratnayake et al., Sci Rep, 2018; [5] NIH ODS, Lutein/Zeaxanthin; [6] Kubota et al., Retina, 2014.

Other names
HEV lightShort-wavelength visible light400-500 nm radiationBlue-violet light
02

Mechanism of action

Absorption and filtration of high-energy visible light by macular pigments; neutralization of reactive oxygen species; reduction of blue light-absorbing chromophore accumulation.

03

Biological functions

Circadian rhythm regulationVisual phototransductionPupillary light reflexMelatonin suppression
04

Disease associations

Age-related macular degenerationRetinal phototoxicityCircadian rhythm sleep-wake disordersDigital eye strain
05

Safety considerations

Circadian rhythm disruptionPotential impact on scotopic visionSleep-wake cycle interference
06

Interacting drugs

Lutein

8 more in the full profile.

07

Biomarkers

Macular pigment optical density (MPOD)Fundus autofluorescence (FAF)Melatonin levels

Beyond the preview

Go deeper on Blue light (High-energy visible light) (HEV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue light (High-energy visible light) (HEV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call